Factor 8 Ehl denied for failing step therapy by Humana?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for factor 8 ehl are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Factor 8 Ehl
## Why Humana Applies Step Therapy to Extended Half-Life Factor VIII
Step therapy (sometimes called "fail-first" policy) requires that a patient try and document inadequate response to one or more lower-cost or preferred-tier treatments before coverage is approved for a non-preferred option. For extended half-life (EHL) Factor VIII, Humana's step-therapy protocol typically requires documented prior use of at least one standard-acting (non-EHL) Factor VIII concentrate. The denial is issued when records of prior standard-product use are absent or incomplete in the PA submission.
## Why This Denial Is Appealable
Many states have enacted step-therapy reform laws that require insurers to grant an exception when: the preferred medication is contraindicated; the patient already tried and failed the step-therapy product; or requiring the patient to start on a lower-tier product would cause clinically significant delay in appropriate treatment. Even in states without specific step-therapy laws, ERISA and ACA appeal rights protect you. If you have already used standard Factor VIII products, the documentation issue is straightforward to remedy.
## Federal Appeal Rights
- ERISA §503 (employer plans): Full-and-fair review; external review after exhaustion.
- ACA §2719: External IRO review. The request window typically runs approximately four months from the final internal denial — check your denial letter for the exact deadline.
- Expedited review: Available when delay would seriously jeopardize health.
- State step-therapy override: Check whether your state has a step-therapy exception law — these often provide additional and faster override pathways.
## Appeal Process and Timeline
1. Determine whether you qualify for a step-therapy exception (prior failure, contraindication, or state-law override). 2. Gather complete records of all prior standard Factor VIII use. 3. File a Level 1 internal appeal — or a step-therapy exception request if your plan has a separate pathway. 4. If denied, escalate to Level 2 internal or external review.
## Documentation to Gather
- Prior standard Factor VIII treatment records: Pharmacy dispensing records, infusion center logs, or specialty pharmacy invoices confirming the product name, dates of use, and duration.
- Documented inadequacy or exception basis: Chart notes describing breakthrough bleeds, adherence barriers, venous access difficulties, or other clinical reasons standard products were insufficient — or a prescriber attestation that starting on standard product would be clinically inappropriate.
- Prescriber step-therapy exception letter: A letter from the hematologist citing the applicable step-therapy exception criteria and explaining why the EHL product is specifically required.
- Guideline support: Reference to WFH and MASAC guidance regarding appropriate patient selection for EHL products.
## Criteria-Mapping Structure
Obtain Humana's step-therapy policy for Factor VIII and identify each required step:
| Step-Therapy Requirement | Evidence Provided | |---|---| | Prior standard Factor VIII product used | Pharmacy/infusion records with dates | | Duration of prior use met | Dates showing duration | | Inadequate response or exception basis | Chart notes / prescriber letter | | Current prescriber is a hematologist | Credentials documentation |
A step-therapy appeal that directly maps prior treatment history to each required step is among the most straightforward types to win.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →